3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
38
Thoracic
31
Genitourinary
21
Breast
20
Gastrointestinal
15
Head & Neck
8
Dermatologic
7
Gynecologic
4
Sarcoma
2
Other solid neoplasm
2
Lymphoid
2
Plasma cell
1
Other hematologic neoplasm
1
Endocrine
1
CNS
1
Conditions
Thyroid Carcinoma, Anaplastic
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 2a
1
Lung Neoplasms
1
Lethal Congenital Contracture Syndrome 2
1
Head and Neck Neoplasms
1
Esthesioneuroblastoma, Olfactory
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Carcinoma, Neuroendocrine
1
Carcinoma, Medullary
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Adrenocortical Carcinoma
1
Adenocarcinoma, Follicular
1
Interventions
Everolimus
6
Sunitinib
4
Octreotide
4
Leucovorin
4
dabrafenib
3
Fluorouracil
3
3-Iodobenzylguanidine
3
trametinib
2
selpercatinib
2
lutetium Lu 177 dotatate
2
avelumab
2
alectinib
2
PM 01183
2
Oxaliplatin
2
Irinotecan
2
Fulvestrant
2
Drug Therapy
2
Doxorubicin
2
Cisplatin
2
trifluridine tipiracil drug combination
1
tipifarnib
1
telotristat ethyl
1
surufatinib
1
somapacitan
1
ribociclib
1
repotrectinib
1
pralsetinib
1
pentetreotide
1
pegfilgrastim
1
pasireotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Docetaxel
×
Endocrine
×
Clear all
NCT03837977
2024-12-30
NET02
The Christie NHS Foundation Trust
Phase 2
Completed
58 enrolled